drugset

drugset / Trial / NCT00151502

To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.

NCT00151502 ↗

Phase 3 Completed 600 enrolled Viatris Inc.

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to find out if atovastatin, when taken with a cholinesterase inhibitor, is effective for treating Alzheimer's disease.

Timeline

Start: 2002-11
Primary completion: —
Completion: 2007-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Atorvastatin	Small molecule	80 mg	—

Indications